Becton to sell Clontech to Takara Bio:
This article was originally published in Clinica
Executive Summary
Becton Dickinson has agreed to sell its Mountain View, California-based Clontech business, which makes biological products for the life science market as part of the group's BD Biosciences division, to Takara Bio, of Otsu, Japan. Becton Dickinson announced its intention to sell the Mountain View, California business in October 2004. Takara Bio will pay $60m, or about the same as Clontech's fiscal 2004 revenues. The transaction is expected to close by August 2005.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.